Related Experiment Videos
Pulmonary blastoma: remission with chemotherapy
European Journal of Respiratory Diseases
|July 1, 1984
Summary
A pulmonary blastoma recurrence in a 59-year-old man achieved complete remission with combination chemotherapy. The treatment included CCNU, vincristine, VP-16, and cyclophosphamide, showing efficacy in this rare lung cancer.
Area of Science:
- Oncology
- Pulmonary Medicine
- Cancer Research
Background:
- Pulmonary blastoma is a rare and aggressive primary lung cancer.
- Recurrence after initial treatment poses significant therapeutic challenges.
Observation:
- A 59-year-old male patient with pulmonary blastoma experienced tumor relapse 7 months post-pneumonectomy.
- Histopathological and ultrastructural analyses confirmed recurrence consistent with the primary tumor.
- Cell kinetic studies indicated a high proportion of tumor cells in the S-phase of the cell cycle.
Findings:
- Combination chemotherapy including CCNU, vincristine, VP-16, and cyclophosphamide was initiated.
- Complete remission of the pulmonary blastoma recurrence was achieved rapidly, within 16 days.
- The observed S-phase fraction correlated with treatment response.
Implications:
- This case highlights the potential efficacy of multi-agent chemotherapy in managing recurrent pulmonary blastoma.
- Rapid tumor cell proliferation (high S-phase fraction) may predict a favorable response to chemotherapy.
- Further research into cell kinetic-guided chemotherapy for rare lung cancers is warranted.